NEW YORK (GenomeWeb News) – DNAPrint Genomics today said it and a Spanish biotech will try to identify genes linked to how individuals with ovarian cancer respond to certain chemotherapeutic agents.
Terms of the deal call for DNAPrint to test DNA samples collected by NeoCodex of Seville to study “the effectiveness of certain treatments for ovarian cancer” involving Taxotere, Taxol, Carboplatin, and Cisplatin.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

Berkeley researchers have engineered yeast to make the molecule behind the hoppy taste of beer, Quartz reports.

King's College London researchers examine the influence of school type and genetics on academic achievement.

FiveThirtyEight writes that most who take a direct-to-consumer BRCA1/2 genetic test won't learn much from it.

In Science this week: early life experience influence somatic variation in the genome, and more.

Sponsored by
Thermo Fisher Scientific

In this webinar, the first in the “New Frontiers in Liquid Biopsy Research” series, Bea Bellosillo, head of pathology at the Hospital del Mar, will discuss her experience evaluating an early-access lung cancer panel that detects copy number variants and fusions.